OncoCyte Corp (OCX) — Financial Flexibility Index
OncoCyte Corp (OCX) has a Financial Flexibility Index of -0.11x as of March 2025. Free cash flow of $-5.55 Million (operating CF $-5.86 Million minus capex $307.00K) represents 0% of total liabilities ($50.14 Million). Check strategic asset allocation of OncoCyte Corp to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
OncoCyte Corp Financial Flexibility Index (2013–2024)
Historical Financial Flexibility Index trend for OncoCyte Corp across 12 annual periods. See OncoCyte Corp short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for OncoCyte Corp (2013–2024)
Year-by-year free cash flow to debt coverage for OncoCyte Corp. For the full company profile including market capitalisation, see OncoCyte Corp (OCX) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.43x | $-20.20 Million | $-20.71 Million | $47.35 Million | ▲ +8.8% |
| 2023 | -0.47x | $-23.04 Million | $-23.32 Million | $49.30 Million | ▲ +25.4% |
| 2022 | -0.63x | $-41.23 Million | $-45.57 Million | $65.80 Million | ▼ -75.4% |
| 2021 | -0.36x | $-33.69 Million | $-35.94 Million | $94.35 Million | ▲ +68.4% |
| 2020 | -1.13x | $-24.75 Million | $-25.98 Million | $21.94 Million | ▲ +45.8% |
| 2019 | -2.08x | $-18.80 Million | $-19.71 Million | $9.02 Million | ▼ -9.3% |
| 2018 | -1.91x | $-11.62 Million | $-11.65 Million | $6.09 Million | ▲ +16.7% |
| 2017 | -2.29x | $-13.29 Million | $-13.38 Million | $5.81 Million | ▼ -41.4% |
| 2016 | -1.62x | $-7.42 Million | $-7.52 Million | $4.58 Million | ▼ -0.4% |
| 2015 | -1.61x | $-3.73 Million | $-4.23 Million | $2.31 Million | ▼ -936.7% |
| 2014 | -0.16x | $-1.16 Million | $-1.16 Million | $7.43 Million | ▼ -6.0% |
| 2013 | -0.15x | $-685.00K | $-710.00K | $4.67 Million | — |